GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beryl Drugs Ltd (BOM:524606) » Definitions » Shiller PE Ratio

Beryl Drugs (BOM:524606) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Beryl Drugs Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Beryl Drugs Shiller PE Ratio Historical Data

The historical data trend for Beryl Drugs's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beryl Drugs Shiller PE Ratio Chart

Beryl Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 9.76 12.57 14.06 -

Beryl Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.06 17.60 22.64 22.68 -

Competitive Comparison of Beryl Drugs's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Beryl Drugs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beryl Drugs's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beryl Drugs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Beryl Drugs's Shiller PE Ratio falls into.



Beryl Drugs Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Beryl Drugs's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Beryl Drugs's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.68/153.0345*153.0345
=-0.680

Current CPI (Mar. 2024) = 153.0345.

Beryl Drugs Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.140 94.103 0.228
201409 0.300 96.780 0.474
201412 0.122 96.780 0.193
201503 -0.399 97.163 -0.628
201506 0.220 99.841 0.337
201509 0.320 101.753 0.481
201512 0.074 102.901 0.110
201603 -0.241 102.518 -0.360
201606 0.241 105.961 0.348
201609 0.202 105.961 0.292
201612 -0.176 105.196 -0.256
201703 -0.040 105.196 -0.058
201706 0.191 107.109 0.273
201709 1.070 109.021 1.502
201712 0.202 109.404 0.283
201803 1.728 109.786 2.409
201806 0.399 111.317 0.549
201809 0.280 115.142 0.372
201812 0.280 115.142 0.372
201903 0.200 118.202 0.259
201906 0.680 120.880 0.861
201909 0.340 123.175 0.422
201912 0.180 126.235 0.218
202003 -1.030 124.705 -1.264
202006 -0.390 127.000 -0.470
202009 0.960 130.118 1.129
202012 -0.340 130.889 -0.398
202103 0.230 131.771 0.267
202106 0.670 134.084 0.765
202109 -0.830 135.847 -0.935
202112 -0.200 138.161 -0.222
202203 -0.940 138.822 -1.036
202206 0.430 142.347 0.462
202209 0.670 144.661 0.709
202212 0.280 145.763 0.294
202303 0.130 146.865 0.135
202306 1.050 150.280 1.069
202309 0.540 151.492 0.545
202312 0.610 152.924 0.610
202403 -0.680 153.035 -0.680

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beryl Drugs  (BOM:524606) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Beryl Drugs Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Beryl Drugs's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beryl Drugs (BOM:524606) Business Description

Traded in Other Exchanges
N/A
Address
133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001
Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.

Beryl Drugs (BOM:524606) Headlines

No Headlines